These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15297635)

  • 1. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
    Beckman M
    Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
    [No Abstract]   [Full Text] [Related]  

  • 2. [Perspectives in immunotherapy of Alzheimer's disease].
    Rossi G
    Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomedicine. Tauists and beta-aptists united--well almost!
    Lee VM
    Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
    [No Abstract]   [Full Text] [Related]  

  • 4. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
    Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearing tau pathology with Abeta immunotherapy--reversible and irreversible stages revealed.
    Hutton M; McGowan E
    Neuron; 2004 Aug; 43(3):293-4. PubMed ID: 15294135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
    Eriksen JL; Janus CG
    Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abeta vaccine therapy for Alzheimer's disease].
    Hara H
    Rinsho Shinkeigaku; 2005 Nov; 45(11):867-9. PubMed ID: 16447748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
    Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J
    Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
    Götz J; Chen F; van Dorpe J; Nitsch RM
    Science; 2001 Aug; 293(5534):1491-5. PubMed ID: 11520988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's cure?
    Schub T
    Lab Anim (NY); 2001 Apr; 30(4):12. PubMed ID: 11385737
    [No Abstract]   [Full Text] [Related]  

  • 13. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: Abeta, tau and synaptic dysfunction.
    LaFerla FM; Oddo S
    Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting alzheimer amyloid plaques in vivo.
    Wengenack TM; Curran GL; Poduslo JF
    Nat Biotechnol; 2000 Aug; 18(8):868-72. PubMed ID: 10932157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: Moving towards a vaccine.
    Holtzman DM
    Nature; 2008 Jul; 454(7203):418-20. PubMed ID: 18650906
    [No Abstract]   [Full Text] [Related]  

  • 17. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hopes remain for an Alzheimer's vaccine.
    Schenk D
    Nature; 2004 Sep; 431(7007):398. PubMed ID: 15385984
    [No Abstract]   [Full Text] [Related]  

  • 19. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
    Schenk D
    Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.